This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

EDWARD M. SHAPIRO, M.D.; JOHN M. KNOX, M.D.; SCOTT GRUNDY, B.S.

AMA Arch Derm. 1960;81(6):940-943.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

If psoriasis is a disease of systemic lipid metabolism, some deviation from the normal should be found in the serum lipoprotein levels of psoriatic patients. It has been shown that the lipid constituents in the serum, including phospholipids, neutral fats, triglycerides, cholesterol, and cholesterol esters, are carried primarily as lipid-protein complexes called lipoproteins.^1,2 The best method at present for studying these relatively unstable compounds is by the technique of ultracentrifugation. This study was undertaken to determine what changes, if any, occur in serum lipoprotein fractions of patients with psoriasis when treated by various means.

In recent publications it has been demonstrated that patients with psoriasis show no consistent variation from the normal with regard to serum lipoproteins. No significant abnormalities were found by Lea et al.³ in the serum lipoproteins of patients with psoriasis, and these findings were confirmed in our own preliminary report.⁴ The possibility remains, . . . [Full Text PDF of this Article]

Author Affiliations
Houston, Texas

From the Department of Dermatology, Everett R. Seale, Chairman, and the Department of Biochemistry, Baylor University College of Medicine, Houston, Texas.

Footnotes
Submitted for publication Oct. 9, 1959.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?